Universe Pharmaceuticals INC Depreciation
Universe Pharmaceuticals INC (UPC) reported Depreciation of $474.18 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-01-29
| Period end | Depreciation 6 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $474.18M 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $474.03M 20-F · filed 2026-01-29 | $474.03K 20-F · filed 2025-04-29 | |
| 2024-03-31 | $246.37K 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $503.69M 20-F · filed 2026-01-29 | $503.69K 20-F · filed 2024-01-30 | |
| 2023-03-31 | $255.20K 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $528.92K 20-F · filed 2025-04-29 | ||
| 2022-03-31 | $289.29K 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $441.36K 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $240.72K 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $404.95K 20-F · filed 2023-02-10 | ||
| 2019-09-30 | $413.20K 20-F · filed 2022-01-31 |